Studienprotokoll
Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma
SECI Oncology Journal · 28.04.2026 · 14 (2) · 63-71
DOI: 10.21608/secioj.2026.502155 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift SECI Oncology Journal, online erschienen am 28.04.2026.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma. SECI Oncology Journal, 14(2), 63-71. https://doi.org/10.21608/secioj.2026.502155
Vancouver
Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma. SECI Oncology Journal. 2026;14(2):63-71. doi:10.21608/secioj.2026.502155
BibTeX
@article{euvimed2026,
title = {Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma},
journal = {SECI Oncology Journal},
year = {2026},
volume = {14},
number = {2},
pages = {63--71},
doi = {10.21608/secioj.2026.502155}
}
EUVIMED